Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Y Jiang, P Zhang, X Zhang, L Lv, Y Zhou - Cell proliferation, 2021 - Wiley Online Library
Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and
microstructural degeneration. The personal and societal costs of osteoporosis are …
microstructural degeneration. The personal and societal costs of osteoporosis are …
Mesenchymal stem cells: key players in cancer progression
SM Ridge, FJ Sullivan, SA Glynn - Molecular cancer, 2017 - Springer
Tumour progression is dependent on the interaction between tumour cells and cells of the
surrounding microenvironment. The tumour is a dynamic milieu consisting of various cell …
surrounding microenvironment. The tumour is a dynamic milieu consisting of various cell …
[HTML][HTML] Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy?
A De Becker, I Van Riet - World journal of stem cells, 2016 - ncbi.nlm.nih.gov
Mesenchymal stromal cells (MSCs) are currently being investigated for use in a wide variety
of clinical applications. For most of these applications, systemic delivery of the cells is …
of clinical applications. For most of these applications, systemic delivery of the cells is …
Immunosuppressive properties of mesenchymal stem cells: advances and applications
MP De Miguel, S Fuentes-Julian… - Current molecular …, 2012 - ingentaconnect.com
Mesenchymal stem cells (MSCs) have been isolated from a variety of tissues, such as bone
marrow, skeletal muscle, dental pulp, bone, umbilical cord and adipose tissue. MSCs are …
marrow, skeletal muscle, dental pulp, bone, umbilical cord and adipose tissue. MSCs are …
Mesenchymal stem cells in health and disease
Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can
be isolated from many adult tissues. They can differentiate into cells of the mesodermal …
be isolated from many adult tissues. They can differentiate into cells of the mesodermal …
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
CD2+ T lymphocytes obtained from either the donor of bone marrow stromal cells (BMSCs)
or a third party were cultured in mixed lymphocyte reactions (MLRs) with either allogeneic …
or a third party were cultured in mixed lymphocyte reactions (MLRs) with either allogeneic …
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation
TT William, JD Pendleton, WM Beyer, MC Egalka… - …, 2003 - journals.lww.com
Background. Marrow stromal cells (MSC) can differentiate into multiple mesenchymal
tissues. To assess the feasibility of human MSC transplantation, we evaluated the in vitro …
tissues. To assess the feasibility of human MSC transplantation, we evaluated the in vitro …
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
C Campagnoli, IAG Roberts, S Kumar… - Blood, The Journal …, 2001 - ashpublications.org
Human mesenchymal stem/progenitor cells (MSCs) have been identified in adult bone
marrow, but little is known about their presence during fetal life. MSCs were isolated and …
marrow, but little is known about their presence during fetal life. MSCs were isolated and …
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
K Le Blanc, L Tammik, B Sundberg… - Scandinavian …, 2003 - Wiley Online Library
We aimed to study the effects of mesenchymal stem cells (MSCs) on alloreactivity and
effects of T‐cell activation on human peripheral blood lymphocytes (PBLs) in vitro. MSCs …
effects of T‐cell activation on human peripheral blood lymphocytes (PBLs) in vitro. MSCs …